Shanghai Runda Medical Tec (603108.SS) traded flat 0 % during a 24 hours period ending at 10:34 PM Central Europe on Monday 26th. One Shanghai Runda Medical Tec stock can currently be bought for about CNY 10.23 on popular exchanges. Current supply of Shanghai Runda Medical Tec stocks is 604.8 mn. Shanghai Runda Medical Tec has a current market capitalization of CNY 6.1 bn and approximately CNY 295.5 mn worth of Shanghai Runda Medical Tec was traded on exchanges in the last 24 hours. Since last month end, Shanghai Runda Medical Tec has traded 0.9 % up. Simple moving average of last 200 days is at CNY 10.04. The highest price of past 52 weeks was recorded at CNY 20.77 on 01/13/2026. 52 weeks low was at CNY 8.7 on 07/09/2026.
Summary of the latest news for Shanghai Runda Medical Tec
Shanghai Runda Medical Tec has seen a modest uptick in attention from institutional investors amid a broader revival in the medical‑commercial sector. Analysts note that the company’s recent earnings release reflected a continuation of the performance recovery observed across the industry, driven in part by policy incentives that broadened drug listings and encouraged retail consolidation. Runda’s focus on medical device distribution and its alignment with national initiatives aimed at improving pricing mechanisms and supporting high‑quality retail operations have been cited as factors that may support future growth prospects. While the firm’s market movement remains mixed, the combination of solid earnings and supportive regulatory developments has generated a cautiously optimistic view among market participants.
Here is how related stocks have performed in the past 24 hours:
Tinavi Medical Technologie (688277.SS) traded flat 0 % and now trades at CNY 17.35. Tinavi Medical Technologie has a market capitalisation of CNY 7.3 bn. On October 23, several shares attracted significant financing interest, according to data from the Securities Times. The most heavily financed stocks were led by Zhongji Xuchuang, followed by Ningde Time and Xinyisheng, which collectively drew a large portion of the day’s borrowing activity. The report highlighted the share prices and transaction volumes of these and other stocks, noting that the financing purchases represented a notable share of their total trading. While the article does not provide specific numerical values, it underscores the market’s focus on newly funded securities and the relative weight of borrowing in the day’s trading activity.
Fujian Dongbai (600693.SS) traded flat 0 % and now trades at CNY 9.02. Fujian Dongbai has a market capitalisation of CNY 7.3 bn. Current price/earnings ratio for Fujian Dongbai is 147.33. On October 26, 2026, market activity in China’s A‑share market was generally subdued at open, but several sectors experienced notable movements. The robotics and consumer‑electronics clusters saw intermittent gains, while sectors tied to industrial gases, shipping, and certain commodity groups posted modest rises. In the retail domain, a number of listed retailers, including a prominent department store chain, experienced a sequence of consecutive price increases, reflecting broader consumer‑spending momentum reported by the Ministry of Commerce. Meanwhile, the consumer‑goods and beverage sectors remained volatile, with a few firms trading higher amid expectations of continued adjustments in the industry. The day also featured brief activity around brain‑computer interface technology, prompting a temporary lift for related companies. Overall, the market displayed a mix of selective strength across thematic areas while remaining cautious in light of ongoing economic and policy developments.
Csg Smart Science& Technol (300222.SZ) traded flat 0 % and now trades at CNY 9.06. Csg Smart Science& Technol has a market capitalisation of CNY 7.3 bn. Current price/earnings ratio for Csg Smart Science& Technol is 77.42. On 26 October 2026, the Hong Kong Stock Exchange announced that CSG Smart Science & Technology (SZ300222) had submitted a second listing application to the main board. The company, backed by Haitai International and Guoyuan International, positions itself as a major player in power‑equipment, energy storage and robotics, aiming to advance digital transformation across China’s energy and manufacturing sectors. The filing highlights a shift from past aggressive acquisitions to a focus on core operations. Earlier high‑profile purchases—such as full ownership of Shanghai Guanzhi Industrial Automation and Huaxiao Precision Industrial—were later written off due to significant goodwill impairments. The company subsequently divested these assets at markedly lower prices, reflecting earlier strategic adjustments. Additionally, CSG Smart has divested several subsidiaries, converting them into non‑consolidated entities while maintaining substantial supply‑chain relationships with them. These actions illustrate an ongoing restructuring effort to streamline its balance sheet and governance framework.
Shenzhen Laibao Hi-tech (002106.SZ) traded flat 0 % and now trades at CNY 10.16. Current market capitalisation for Shenzhen Laibao Hi-tech is CNY 7.3 bn. Current price/earnings ratio for Shenzhen Laibao Hi-tech is 35.54.
Shenzhen Das Intellitech (002421.SZ) traded flat 0 % and now trades at CNY 3.42. Current market capitalisation for Shenzhen Das Intellitech is CNY 7.3 bn. Shenzhen Das Intellitech (002421.SZ) released its third‑quarter 2026 financial results on October 26. The company reported that institutional investors now hold 13.29 % of its shares, down from the prior quarter. Six institutional holders disclosed holdings totaling 282 million shares, representing a decline of 4.78 percentage points compared with the previous reporting period. The institutional investors include domestic and international entities such as Changde City Das Enterprise Management Group, Hong Kong Central Securities Clearing Co., Goldman Sachs (own funds), UBS AG, Morgan Stanley & Co. International PLC, and J.P. Morgan Securities (own funds). The data indicate a modest contraction in institutional ownership during the quarter, reflecting a shift in investment dynamics for the company.
About Shanghai Runda Medical Tec
Shanghai Runda Medical Technology Co., Ltd. is a health care company operating in the Life Sciences Tools & Services sector. The company, based in Shanghai, distribution medical instruments. Their product range includes In vitro diagnostic equipment, supporting reagents, and other products. They market their products worldwide, with their official website being www.rundamedical.com and their stock being traded on the Shanghai Stock Exchange.
